Yifan Pharmaceutical Co., Ltd. (SZSE: 002019)
Health Care · Pharmaceuticals · CN
CN¥10.13
-4.52% today · -37.8% 1Y
Yifan Pharmaceutical Co., Ltd. (SZSE: 002019) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.56B and employs 4,221 people.
Over the last twelve months the share price has lost 37.8%, trading between 9.07 and 16.53.
Tweenvest scores Yifan Pharmaceutical Co., Ltd. across four factors: quality 62/100, value 76/100, growth 7/100, dividend 50/100. Its strongest factor is value.
002019 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.56B
- Revenue (TTM)
- $733.88M
- P/E
- 34.70
- EPS
- 0.29
- Dividend yield
- 0.99%
- Beta (5Y)
- 0.46
- 52-week high
- CN¥16.53
- 52-week low
- CN¥9.07
- Avg volume (3M)
- —
- Shares outstanding
- 1.04B
- Employees
- 4,221
- Next earnings
- —
About Yifan Pharmaceutical Co., Ltd.
Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, sale of pharmaceutical products, active pharmaceutical ingredients and polymer materials. It provides blood tumors, gynecology, pediatrics, skin, orthopedic drugs, phosphate buffered saline, polyvinyl butyral products, vitamin B5 and original B5. The company was founded on November 10, 2000 and is headquartered in Hangzhou, China.
- ISIN
- CNE000001K65
- Founded
- 2000
- Listed since
- Jul 13, 2004
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.